These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19403314)

  • 1. New antituberculotics originated from salicylanilides with promising in vitro activity against atypical mycobacterial strains.
    Imramovský A; Vinsová J; Férriz JM; Dolezal R; Jampílek J; Kaustová J; Kunc F
    Bioorg Med Chem; 2009 May; 17(10):3572-9. PubMed ID: 19403314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relation between chemical structure and antimycobacterial activity against atypical strains. XIII. Thiosalicylanilides].
    Waisser K; Kubicová L; Gregor J; Budová J; Andrlová A; Drsata J; Odlerová Z
    Ceska Slov Farm; 1998 Mar; 47(2):84-6. PubMed ID: 9650366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
    Férriz JM; Vávrová K; Kunc F; Imramovský A; Stolaríková J; Vavríková E; Vinsová J
    Bioorg Med Chem; 2010 Feb; 18(3):1054-61. PubMed ID: 20060303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oriented development of antituberculotics: salicylanilides.
    Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
    Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
    Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
    Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-benzylsalicylthioamides: highly active potential antituberculotics.
    Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
    Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oriented development of antituberculotics (Part II): halogenated 3-(4-alkylphenyl)-1,3-benzoxazine-2,4-(3H)-diones.
    Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Palát K; Kaustová J
    Arch Pharm (Weinheim); 2007 May; 340(5):264-7. PubMed ID: 17516578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antimicrobial salicylanilides and 3-phenyl-2H-1,3-benzoxazine-2,4(3H)-diones].
    Waisser K; Gregor J; Holý P; Kubicová L; Klimesová V; Kaustová J
    Ceska Slov Farm; 2001 May; 50(3):148-52. PubMed ID: 11394023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Azabischalcones--a new class of potential antitubercular agents].
    Kozmík V; Lhoták P; Odlerová Z; Palecek J
    Ceska Slov Farm; 1998 Mar; 47(2):87-90. PubMed ID: 9650367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salicylanilide esters of N-protected amino acids as novel antimicrobial agents.
    Imramovský A; Vinsová J; Férriz JM; Buchta V; Jampílek J
    Bioorg Med Chem Lett; 2009 Jan; 19(2):348-51. PubMed ID: 19081718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of antitubercular salicylanilides consistent with disruption of the proton gradient via proton shuttling.
    Lee IY; Gruber TD; Samuels A; Yun M; Nam B; Kang M; Crowley K; Winterroth B; Boshoff HI; Barry CE
    Bioorg Med Chem; 2013 Jan; 21(1):114-26. PubMed ID: 23211970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New amino acid esters of salicylanilides active against MDR-TB and other microbes.
    Krátký M; Vinšová J; Buchta V; Horvati K; Bösze S; Stolaříková J
    Eur J Med Chem; 2010 Dec; 45(12):6106-13. PubMed ID: 20937542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase.
    Krátký M; Vinšová J; Novotná E; Stolaříková J
    Eur J Pharm Sci; 2014 Mar; 53():1-9. PubMed ID: 24333643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents.
    Klimesová V; Kocí J; Waisser K; Kaustová J; Möllmann U
    Eur J Med Chem; 2009 May; 44(5):2286-93. PubMed ID: 18694614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel salicylanilides from 4,5-dihalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
    Paraskevopoulos G; Monteiro S; Vosátka R; Krátký M; Navrátilová L; Trejtnar F; Stolaříková J; Vinšová J
    Bioorg Med Chem; 2017 Feb; 25(4):1524-1532. PubMed ID: 28126437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimycobacterial assessment of Salicylanilide benzoates including multidrug-resistant tuberculosis strains.
    Krátký M; Vinšová J; Stolaříková J
    Molecules; 2012 Oct; 17(11):12812-20. PubMed ID: 23114617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimycobacterial activity of salicylanilide benzenesulfonates.
    Krátký M; Vinšová J; Rodriguez NG; Stolaříková J
    Molecules; 2012 Jan; 17(1):492-503. PubMed ID: 22222908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes.
    Pieroni M; Lilienkampf A; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Oct; 52(20):6287-96. PubMed ID: 19757815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings.
    Biava M; Porretta GC; Poce G; De Logu A; Saddi M; Meleddu R; Manetti F; De Rossi E; Botta M
    J Med Chem; 2008 Jun; 51(12):3644-8. PubMed ID: 18494459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitubercular agents. 45. Antimycobacterial thiohydrazide].
    Waisser K; Odlerová Z; Houngbedji N; Thiel W; Mayer R
    Zentralbl Mikrobiol; 1989; 144(5):355-7. PubMed ID: 2515678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.